Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ICCM NASDAQ:LUNG NASDAQ:NXGL NASDAQ:QTI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeICCMIceCure Medical$0.99-0.8%$0.98$0.48▼$1.66$68.22M0.331.89 million shs584,429 shsLUNGPulmonx$1.70+0.6%$2.14$1.47▼$9.37$68.86M0.43562,197 shs248,472 shsNXGLNexGel$2.41-2.4%$2.44$2.10▼$5.10$19.93M0.5843,266 shs26,276 shsQTIQT Imaging$2.50-0.4%$2.09$0.35▼$0.84$67.84M-0.2183,964 shs13,096 shs5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceICCMIceCure Medical-0.76%-4.32%+17.32%+1.39%+59.70%LUNGPulmonx+0.59%-2.30%+10.39%-43.89%-78.06%NXGLNexGel-2.43%+8.56%+0.42%-5.86%-12.68%QTIQT Imaging0.00%+1.63%+25.63%+201.57%+316.74%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeICCMIceCure Medical$0.99-0.8%$0.98$0.48▼$1.66$68.22M0.331.89 million shs584,429 shsLUNGPulmonx$1.70+0.6%$2.14$1.47▼$9.37$68.86M0.43562,197 shs248,472 shsNXGLNexGel$2.41-2.4%$2.44$2.10▼$5.10$19.93M0.5843,266 shs26,276 shsQTIQT Imaging$2.50-0.4%$2.09$0.35▼$0.84$67.84M-0.2183,964 shs13,096 shs5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceICCMIceCure Medical-0.76%-4.32%+17.32%+1.39%+59.70%LUNGPulmonx+0.59%-2.30%+10.39%-43.89%-78.06%NXGLNexGel-2.43%+8.56%+0.42%-5.86%-12.68%QTIQT Imaging0.00%+1.63%+25.63%+201.57%+316.74%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceICCMIceCure Medical 3.00Buy$2.39142.01% UpsideLUNGPulmonx 2.56Moderate Buy$7.66350.84% UpsideNXGLNexGel 0.00N/AN/AN/AQTIQT Imaging 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest NXGL, ICCM, LUNG, and QTI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/8/2025LUNGPulmonxD. Boral CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$16.008/15/2025ICCMIceCure MedicalHC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$2.50 ➝ $2.008/15/2025ICCMIceCure MedicalZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold8/13/2025ICCMIceCure MedicalBrookline Capital ManagementSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy8/13/2025ICCMIceCure MedicalLoop CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$2.778/1/2025LUNGPulmonxWells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetEqual Weight$6.00 ➝ $3.007/31/2025LUNGPulmonxLake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$12.00 ➝ $8.007/31/2025LUNGPulmonxStifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$16.00 ➝ $5.007/31/2025LUNGPulmonxD. Boral CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$17.00 ➝ $16.007/31/2025LUNGPulmonxPiper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeOverweight ➝ Neutral$9.00 ➝ $2.50(Data available from 9/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookICCMIceCure Medical$3.29M20.58N/AN/A$0.12 per share8.21LUNGPulmonx$83.79M0.83N/AN/A$2.17 per share0.78NXGLNexGel$8.69M2.24N/AN/A$0.90 per share2.68QTIQT Imaging$4.00M16.97N/AN/A($1.91) per share-1.31Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateICCMIceCure Medical-$15.32M-$0.16N/AN/AN/A-317.62%-136.96%-71.46%11/25/2025 (Estimated)LUNGPulmonx-$56.39M-$1.43N/AN/AN/A-62.88%-69.76%-36.26%10/29/2025 (Estimated)NXGLNexGel-$3.28M-$0.40N/A∞N/A-25.02%-49.37%-25.68%11/12/2025 (Estimated)QTIQT Imaging-$4.03MN/A0.00∞N/AN/AN/A-65.94%11/11/2025 (Estimated)Latest NXGL, ICCM, LUNG, and QTI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/13/2025Q2 2025ICCMIceCure Medical-$0.06$0.06+$0.12$0.06$0.90 million$0.66 million8/12/2025Q2 2025NXGLNexGel-$0.07-$0.09-$0.02-$0.09$3.08 million$2.88 million7/30/2025Q2 2025LUNGPulmonx-$0.40-$0.38+$0.02-$0.38$23.46 million$23.86 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthICCMIceCure MedicalN/AN/AN/AN/AN/ALUNGPulmonxN/AN/AN/AN/AN/ANXGLNexGelN/AN/AN/AN/AN/AQTIQT ImagingN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioICCMIceCure Medical0.021.180.88LUNGPulmonx0.545.354.63NXGLNexGel0.161.740.98QTIQT ImagingN/A1.060.48Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipICCMIceCure Medical0.62%LUNGPulmonx91.04%NXGLNexGel2.21%QTIQT Imaging24.19%Insider OwnershipCompanyInsider OwnershipICCMIceCure Medical2.44%LUNGPulmonx6.80%NXGLNexGel20.55%QTIQT Imaging75.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableICCMIceCure Medical6068.70 million67.02 millionNot OptionableLUNGPulmonx25040.75 million37.98 millionOptionableNXGLNexGel108.07 million6.41 millionNot OptionableQTIQT ImagingN/A27.13 million6.68 millionN/ANXGL, ICCM, LUNG, and QTI HeadlinesRecent News About These CompaniesQT Imaging (NASDAQ:QTI) Stock Price Down 1.3% - Time to Sell?September 1, 2025 | marketbeat.comQT Imaging (NASDAQ:QTI) Trading Down 1.3% - Here's WhySeptember 1, 2025 | marketbeat.comQT Imaging Appoints Seasoned Accounting Executive as Chief Financial OfficerAugust 28, 2025 | finance.yahoo.comQT Imaging Receives $5.0 Million in New Funding from Lynrock Lake to Repurchase and Cancel All Yorkville WarrantsAugust 27, 2025 | mms.businesswire.comQT Imaging Holdings Signs Saudi Distribution DealAugust 26, 2025 | msn.comQT Imaging Inks Exclusive Distribution Agreement with Gulf Medical for Saudi ArabiaAugust 25, 2025 | mms.businesswire.comQT Imaging Inks Exclusive Distribution Agreement with Gulf Medical for Saudi ArabiaAugust 25, 2025 | businesswire.comQT Imaging Announces Continuous Strong Revenue Growth and Enhanced Balance Sheet in the Second Quarter 2025August 7, 2025 | finance.yahoo.comQT Imaging Launches QTviewer 2.8 to Enhance Clinical Efficiency and Diagnostic AccuracyJuly 17, 2025 | businesswire.comQT Imaging Bolsters Medical and Clinical Leadership with Senior Appointments to Further Drive Innovation and Clinical AdoptionJuly 8, 2025 | finance.yahoo.comQT Imaging to Hold Virtual 2025 Annual Meeting of Stockholders on August 19July 3, 2025 | businesswire.comQT Imaging Leverages NVIDIA L40 GPU Acceleration to Power its Next-Gen Breast Imaging Reconstruction SoftwareJune 25, 2025 | tmcnet.comLadenburg Thalmann Initiates Coverage of QT Imaging Holdings (QTIH) with Buy RecommendationMay 20, 2025 | msn.comQT Imaging Holdings Delivers Its Breast Imaging Scanner to Innovative Radiology in Des Moines, IowaMay 15, 2025 | finance.yahoo.comQT Imaging Holdings Announces $200,000 PIPE InvestmentMay 14, 2025 | joplinglobe.comJQT Imaging Announces First Quarter 2025 Financial ResultsMay 13, 2025 | businesswire.comQT Imaging Approves Executive Stock Options PlanApril 23, 2025 | tipranks.comQT Imaging Holdings Announces $500,000 Insiders PIPE InvestmentApril 10, 2025 | businesswire.comQT Imaging Holdings Announces $500,000 Insiders PIPE InvestmentApril 10, 2025 | businesswire.comQT Imaging Holdings to Participate in the 2025 SBI Breast Imaging SymposiumApril 8, 2025 | businesswire.comQT Imaging Announces Fourth Quarter and Full Year 2024 Financial Results and Provides 2025/26 OutlookApril 2, 2025 | seekingalpha.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesBuffett Makes Big Moves Outside of UNH: A Buy and Sell BreakdownBy Leo Miller | August 18, 20253 Companies That Will Profit From Trump's Semiconductor TariffsBy Jordan Chussler | August 14, 20253 Robotics Stocks at the Heart of the Robotics RevolutionBy Chris Markoch | August 21, 2025NIO Just Got Its Second Upgrade of the Month, and It’s BigBy Sam Quirke | August 28, 2025Dollar Tree Plunges Into Buy-Zone: A Robust Rebound Is ExpectedBy Thomas Hughes | September 4, 2025NXGL, ICCM, LUNG, and QTI Company DescriptionsIceCure Medical NASDAQ:ICCM$0.99 -0.01 (-0.76%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$0.99 +0.01 (+0.66%) As of 09/12/2025 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.Pulmonx NASDAQ:LUNG$1.70 +0.01 (+0.59%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$1.67 -0.03 (-1.76%) As of 09/12/2025 07:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Pulmonx Corporation, a commercial-stage medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. The company offers Zephyr Endobronchial Valve, a solution for the treatment of patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. It also offers StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. The company serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.NexGel NASDAQ:NXGL$2.41 -0.06 (-2.43%) Closing price 09/12/2025 03:59 PM EasternExtended Trading$2.43 +0.02 (+1.00%) As of 09/12/2025 07:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. The company was incorporated in 2009 and is based in Langhorne, Pennsylvania.QT Imaging NASDAQ:QTI$2.50 -0.01 (-0.40%) As of 09/10/2025QT Imaging Holdings, Inc. engages in the research, development, and commercialization of body imaging systems for detection, diagnosis, monitoring, and treatment of diseases. The company offers QT Ultrasound Breast Scanner, an ultrasonic imaging system that provides reflection-mode and transmission-mode images of a patient's breast. QT Imaging Holdings, Inc. was founded in 2011 and is based in Novato, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Post Onum Deal: Is CrowdStrike Ready to Rebound After 16% Drop? Chewy’s September Pullback: Is It Your Time to Buy? It’s Time to Buy the Dip in Kroger Stock Price Is Coupang the Next MercadoLibre? A Playbook for Global Dominance Vanguard’s VUG ETF: The Ultimate Growth ETF for Your Portfolio Tesla's U.S. Market Is At An 8-Year Low... How Bad Could It Get? Not Just NVDA: 3 Semiconductor Stocks Struggling This Quarter Broadcom Gets Big Upgrades: How High Analysts See Shares Going Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
